THE HUMAN GUT MICROBIOME: CONSIDERATIONS TOWARD REGULATORY TESTING FOR DRUGS AND VACCINES
Journal: International Journal of Advanced Research (Vol.9, No. 02)Publication Date: 2021-02-16
Authors : Antonio Villanueva;
Page : 451-452
Keywords : ;
Abstract
Health regulatory authorities worldwide are tasked with approving drugs, medical devices, and vaccines to ensure their safety, efficacy, and quality for public use. Significantly over the past three decades, testing of these products has witnessed increasingly stringent tests due to advancing scientific knowledge and technology. Specifically, the relatively new field of studies on the human gut microbiome and its interactions with drugs and vaccines may accumulate enough evidence in the future to justify its testing prior to regulatory approval or during post-marketing surveillance.
Other Latest Articles
- EVOLUTIONARY ANALYSIS OF GLOBAL OIL AND GAS SECTOR AND ITS IMPACT ON GLOBAL ECONOMY
- COMPARISON BETWEEN YOUNGS DOUBLE SLIT AND ⋀-δ AND â‹Â-δ TYPE THREE LEVEL ATOMS PRODUCING QUANTUM INTERFERENCE
- A STUDY OF AWARENESS AND INFLUENCE OF DEMOGRAPHIC FACTORS ON RISK TOLERANCE OF LAW PROFESSIONALS
- THE SIGNIFICANCE OF THE QUALITY OF CONSUMED FATS AND HYPOTHERMAL STIMULATION IN ANTI-INFLAMMATORY MECHANISMS AND IN THE PREVENTION OF OBESITY
- FANDOM NATION: IDENTIFYING THE SELF-WORTH OF STUDENT INFLUENCERS OF PHILIPPINE SCHOOL DOHA, A PHENOMENOLOGY
Last modified: 2021-03-25 15:15:08